By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company MariMed Inc.

MariMed Inc. (MRMD)

OTC Currency in USD
$0.18
$0.00
-2.54%
Last Update: 3 Sept 2025, 19:58
$69.28M
Market Cap
-4.71
P/E Ratio (TTM)
Forward Dividend Yield
$0.07 - $0.23
52 Week Range

MRMD Stock Price Chart

Explore MariMed Inc. interactive price chart. Choose custom timeframes to analyze MRMD price movements and trends.

MRMD Company Profile

Discover essential business fundamentals and corporate details for MariMed Inc. (MRMD) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

3 Aug 2012

Employees

715.00

CEO

Jon R. Levine

Description

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MRMD Financial Timeline

Browse a chronological timeline of MariMed Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 5 May 2026

Upcoming earnings on 5 Nov 2025

EPS estimate is -$0.01, while revenue estimate is $42.15M.

Earnings released on 6 Aug 2025

EPS came in at -$0.00 surpassing the estimated -$0.01 by +67.50%, while revenue for the quarter reached $39.61M , missing expectations by -2.91%.

Earnings released on 7 May 2025

EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $37.96M , missing expectations by -0.97%.

Earnings released on 5 Mar 2025

EPS came in at -$0.01 matching the estimated -$0.01, while revenue for the quarter reached $39.00M , missing expectations by -7.14%.

Earnings released on 6 Nov 2024

EPS came in at -$0.00 falling short of the estimated -$0.00 by -100.00%, while revenue for the quarter reached $40.59M , missing expectations by -3.35%.

Earnings released on 7 Aug 2024

EPS came in at -$0.00 falling short of the estimated -$0.00 by -99.54%, while revenue for the quarter reached $40.44M , beating expectations by +2.12%.

Earnings released on 8 May 2024

EPS came in at -$0.00 falling short of the estimated -$0.00 by -100.00%, while revenue for the quarter reached $37.93M , beating expectations by +2.66%.

Earnings released on 6 Mar 2024

EPS came in at -$0.03 , while revenue for the quarter reached $38.90M , beating expectations by +0.26%.

Earnings released on 8 Nov 2023

EPS came in at -$0.01 falling short of the estimated -$0.01 by -100.00%, while revenue for the quarter reached $38.80M , missing expectations by -1.52%.

Earnings released on 2 Aug 2023

EPS came in at -$0.00 , while revenue for the quarter reached $36.52M , missing expectations by -7.78%.

Earnings released on 8 May 2023

EPS came in at -$0.00 , while revenue for the quarter reached $34.38M , beating expectations by +4.50%.

Earnings released on 1 Mar 2023

EPS came in at $0.01 surpassing the estimated $0.01 by +100.00%, while revenue for the quarter reached $35.83M , beating expectations by +2.08%.

Earnings released on 7 Nov 2022

EPS came in at $0.01 matching the estimated $0.01, while revenue for the quarter reached $33.91M , missing expectations by -1.99%.

Earnings released on 8 Aug 2022

EPS came in at $0.00 , while revenue for the quarter reached $32.99M , missing expectations by -0.34%.

Earnings released on 10 May 2022

EPS came in at $0.01 matching the estimated $0.01, while revenue for the quarter reached $31.28M , beating expectations by +4.27%.

Earnings released on 16 Mar 2022

EPS came in at -$0.02 falling short of the estimated -$0.00 by -500.60%, while revenue for the quarter reached $31.04M , beating expectations by +7.65%.

Earnings released on 15 Nov 2021

EPS came in at $0.01 , while revenue for the quarter reached $33.21M , beating expectations by +18.14%.

Earnings released on 16 Aug 2021

EPS came in at $0.02 , while revenue for the quarter reached $32.57M .

Earnings released on 17 May 2021

EPS came in at $0.01 , while revenue for the quarter reached $24.64M .

Earnings released on 24 Mar 2021

EPS came in at $0.01 , while revenue for the quarter reached $20.36M .

Earnings released on 9 Nov 2020

EPS came in at $0.00 , while revenue for the quarter reached $13.46M .

MRMD Stock Performance

Access detailed MRMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run